Jaguar Health announces special shareholder meeting

• Jaguar Health scheduled a special shareholder meeting in San Francisco on Sept. 4, 2026.
• Vote on issuing common shares upon exchange of outstanding Series Q Perpetual Preferred Stock held by accredited investors.
• Consider repricing investor warrants for 60,781 common shares to an exercise price of USD 1 per share.
• Warrants, when exercised, also carry rights to receive up to 682,661 common shares tied to the Series O Preferred Stock Dividend.
• Seek approval to amend the 2014 Stock Incentive Plan to authorize share issuance up to 14% of fully diluted shares as of Sept. 30, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jaguar Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-330694), on August 03, 2026, and is solely responsible for the information contained therein.